Treatment of Serous Otitis Media in Children
The recommended initial approach is watchful waiting for 3 months from diagnosis, as 75-90% of cases resolve spontaneously, with tympanostomy tube insertion reserved for persistent bilateral effusion with documented hearing loss after this observation period. 1
Initial Management: Watchful Waiting
- All children without risk factors should be observed for 3 months from the date of effusion onset or diagnosis before considering any intervention. 1
- During this period, monitor using pneumatic otoscopy or tympanometry at clinician discretion. 1
- Parents should be counseled that the child may experience reduced hearing (averaging 25 dB hearing level) until effusion resolves, and strategies to optimize the listening environment should be recommended. 1, 2
- Nasal balloon auto-inflation should be used during watchful waiting due to its low cost, absence of adverse effects, and positive outcomes (NNT = 9 for clearing effusion at 3 months). 2
Medical Therapies: What NOT to Use
The evidence strongly recommends against several commonly used medical treatments:
Ineffective Medications
- Do not use intranasal corticosteroids for OME—they show no improvement in symptoms or middle ear function and may cause adverse effects without clear benefit. 2, 1, 3
- Do not use oral/systemic corticosteroids—they have no long-term benefit and can cause behavioral changes, increased appetite, and weight gain. 1, 3
- Do not use antihistamines or decongestants—a Cochrane meta-analysis found no significant benefit (RR 0.99,95% CI 0.92-1.05). 2, 1, 3
- Do not use systemic antibiotics—they are ineffective for treating OME. 1, 3
Exception for Acute Nasal Congestion
- Topical nasal decongestants (oxymetazoline or xylometazoline) may be used for acute, short-term relief of nasal congestion associated with ETD, but limit use to 3 days maximum to prevent rhinitis medicamentosa. 2
- Use the upside-down (Mygind's) position for nasal drops to optimize delivery to the Eustachian tube opening. 2
Allergy Management
- For OME secondary to allergic rhinitis, treat the underlying allergies with intranasal corticosteroids as first-line therapy for the allergic rhinitis itself (not for the OME). 1
- Second-generation antihistamines can be used for sneezing and itching associated with allergic rhinitis. 1
Monitoring During Observation Period
- Reevaluate every 3-6 months with otologic examination until effusion resolves, significant hearing loss is identified, or structural abnormalities develop. 2, 1
- Obtain age-appropriate hearing testing at 3 months if OME persists or for any duration in at-risk children. 2, 1, 3
- Document findings using pneumatic otoscopy (showing middle ear effusion) and tympanometry (type B flat tympanogram indicating persistent fluid or negative pressure). 2
Criteria for Tympanostomy Tube Placement
Tympanostomy tube insertion is the preferred initial surgical procedure for persistent OME and should be offered when: 2, 1, 3
Specific Indications
- Bilateral effusions for ≥3 months with documented hearing loss (mild hearing loss defined as 16-40 dB HL). 2, 1
- Chronic OME with structural changes of the tympanic membrane (retraction, atelectasis). 2, 1
- Type B (flat) tympanogram indicating persistent fluid or negative pressure after 3 months of observation. 2, 1
Benefits of Tympanostomy Tubes
- High-level evidence shows benefit for hearing and quality of life for up to 9 months. 2
- Clears middle ear effusion for up to 2 years and improves hearing by 6-12 dB while tubes are patent. 2
- No evidence of beneficial effect on language development, so this should not be used as an indication. 2
Age-Specific Surgical Considerations
Children Under 4 Years
- Recommend tympanostomy tubes alone—adenoidectomy should not be performed unless a distinct indication exists (nasal obstruction, chronic adenoiditis) other than OME. 1, 3
Children 4 Years and Older
- Recommend tympanostomy tubes, adenoidectomy, or both. 1, 3
- For repeat surgery, adenoidectomy plus myringotomy (with or without tubes) is recommended unless cleft palate is present. 2, 1
- Adenoidectomy reduces the need for ventilation tube re-insertions by ~10% and confers a 50% reduction in the need for future operations. 2
Special Populations Requiring Earlier Intervention
At-risk children may require earlier or more aggressive intervention and should be considered more vulnerable to OME sequelae: 1, 3
- Children with Down syndrome (require hearing assessments every 6 months starting at birth). 2
- Children with cleft palate (require multidisciplinary management and continued monitoring throughout childhood). 2
- Children with developmental disabilities, craniofacial syndromes, or severe visual impairments. 1
- These children should be evaluated for OME at the time of diagnosis of the at-risk condition and at 12-18 months of age. 3
Critical Pitfalls to Avoid
- Do not insert tympanostomy tubes before 3 months of documented OME—there is no evidence of benefit and it exposes the patient to unnecessary surgical risks. 2
- Do not skip hearing testing before considering surgery—it is essential for appropriate decision-making. 2
- Do not use prolonged or repetitive courses of antimicrobials or steroids—they are strongly not recommended for long-term resolution of OME. 2
- Do not assume OME severity is unrelated to behavioral problems or developmental delays—OME severity correlates with lower IQ, hyperactive behavior, and reading defects. 2
Post-Surgical Management
- Evaluate children within 3 months after tympanostomy tube placement, then periodically while tubes remain in place. 1
- Educate caregivers about tube function duration, follow-up schedule, and how to detect complications. 1
- For ear infections with tubes, use antibiotic ear drops (ofloxacin or ciprofloxacin-dexamethasone) twice daily for up to 10 days—oral antibiotics are generally unnecessary. 2
- Water precautions may be necessary, particularly for swimming in non-chlorinated water or dunking head during bathing. 2, 1